
HNGE Stock Forecast & Price Target
HNGE Analyst Ratings
Bulls say
Hinge Health is seeing positive trends in downloads and expanding to new markets, showcasing their strong growth potential. Their profitability and efforts towards sustainability and employee development make them a promising investment option. While there are potential risks in the competitive landscape and changes in healthcare regulation, analysts have rated the stock as Outperform with a promising price target of $65.
Bears say
Hinge Health is currently experiencing strong revenue growth and margin expansion, leading to positive market sentiment. However, the company's growth momentum is expected to decelerate in the second half of 2021 and long-term growth potential may be limited due to increased competition and potential challenges in driving billing growth through employee utilization. The current valuation of the stock is relatively high compared to peers, and we believe a more conservative price target of $63 is appropriate given these factors.
This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.
HNGE Analyst Forecast & Price Prediction
Start investing in HNGE
Order type
Buy in
Order amount
Est. shares
0 shares